Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT
Inhibrx Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.3M | n/a | 100K | n/a | 100K | n/a | 1.63M | 119K | 30K | 17K | 274K | 278K | 711K | 915K | 2.84M | 2.51M | 918K | 863K |
Cost of Revenue | n/a | 675K | -635K | 761K | 475K | 360K | 298K | -560K | 731K | 722K | 720K | 719K | 29.91M | n/a | n/a | n/a | n/a | 16.44M |
Gross Profit | n/a | -675K | 735K | -761K | -375K | -360K | 1.34M | 679K | -701K | -705K | -446K | -441K | -29.2M | 915K | 2.84M | 2.51M | 918K | -15.57M |
Operating Income | -27.39M | -42.9M | -49.93M | -46.8M | -160.9M | -73.83M | -88.29M | -45.83M | -41.34M | -43.77M | -35.5M | -30M | -34.6M | -29.02M | -19.4M | -18.8M | -19.8M | -18.56M |
Interest Income | 2.12M | 2.33M | 2M | 2.89M | 2.74M | 3.3M | 4.7M | 2.32M | 2.41M | 5.08M | 5.34M | 5.34M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -91.97M | -51.79M | -47.05M | -48.92M | -40.92M | -35.33M | -37.73M | -31.25M | -21.19M | -20.58M | -20.71M | -19.29M |
Net Income | -28.65M | -43.31M | -47.87M | -43.86M | 1.86B | -78.71M | -93.6M | -51.79M | -47.05M | -48.69M | -40.91M | -40.65M | -37.73M | -33.49M | -21.19M | -20.58M | -20.71M | -19.29M |
Selling & General & Admin | 6.42M | 6.02M | 16.66M | 7.9M | 93.37M | 9.87M | 7.79M | 7.89M | 7.26M | 6.4M | 5.32M | 5.35M | 5.4M | 5.05M | 3.65M | 2.85M | 2.85M | 3.01M |
Research & Development | 22.27M | 36.88M | 33.37M | 38.89M | 67.63M | 63.59M | 81.84M | 38.06M | 34.11M | 37.39M | 30.45M | 24.93M | 29.91M | 24.89M | 18.61M | 18.48M | 17.9M | 16.44M |
Other Expenses | n/a | -675K | -689K | n/a | n/a | n/a | n/a | -304K | -217K | -5.15M | -5.42M | -5.32M | 17K | -14K | n/a | -1K | 5K | 16K |
Operating Expenses | 28.69M | 42.23M | 49.34M | 46.8M | 161M | 73.47M | 89.63M | 45.64M | 41.37M | 43.78M | 35.77M | 30.28M | 35.31M | 29.93M | 22.24M | 21.31M | 20.72M | 19.42M |
Interest Expense | -3.14M | -2.69M | n/a | n/a | 5.36M | 8.13M | 8.22M | 8.15M | 7.91M | 5.08M | 5.34M | 5.34M | 3.15M | 2.27M | 1.78M | 1.78M | 914K | 745K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -104K | -46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 42.9M | 50.03M | 46.8M | 161M | 73.83M | 89.92M | 45.95M | 41.37M | 43.78M | 35.77M | 30.28M | 35.31M | 29.93M | 22.24M | 21.31M | 20.72M | 19.42M |
Income Tax Expense | 2K | n/a | n/a | n/a | 2K | 316.72K | -4K | 2K | 5K | -225K | -1K | 5.32M | 4K | 2.24M | n/a | n/a | n/a | 2K |
Shares Outstanding (Basic) | 15.47M | 15.47M | 14.48M | 15.47M | 14.48M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
Shares Outstanding (Diluted) | 15.47M | 15.47M | 14.48M | 15.47M | 14.81M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
EPS (Basic) | -1.85 | -2.8 | -3.31 | -2.84 | 128.35 | -1.44 | -1.73 | -1.1 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 |
EPS (Diluted) | -1.85 | -2.8 | -3.31 | -2.84 | 125.48 | -1.44 | -1.73 | -1.1 | -1.08 | -1.12 | -0.95 | -1.04 | -0.97 | -0.86 | -0.55 | -0.54 | -0.55 | -0.51 |
EBITDA | -27.39M | -42.9M | -47.18M | -43.1M | 1.86B | -70.22M | -87.99M | -43.33M | -38.85M | -41.06M | -35.5M | -30M | -34.27M | -28.67M | -19.4M | -18.5M | -19.5M | -18.25M |
EBIT | n/a | -40.62M | -47.87M | -43.86M | 1.86B | -70.58M | -88.29M | -43.64M | -39.14M | -41.35M | -35.57M | -29.98M | -34.58M | -28.98M | -19.41M | -18.8M | -19.8M | -18.54M |
Depreciation & Amortization | n/a | 675K | 689K | 760K | 476K | 360K | 298K | 304K | 731K | 295K | 720K | 719K | 324K | 344K | 307K | 299K | 298K | 291K |